![Christopher Hite](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 164 M $ in data 31/07/2026
Christopher Hite is Vice Chairman & Executive Vice President at RP Management LLC and Royalty Pharma Plc since 2020.
Holds director roles at FasterCures and Lehigh University.
Independent Director at Kailera Therapeutics, Inc. since 2025 and Vera Therapeutics, Inc. since 2026.
Former Independent Director at Acceleron Pharma, Inc. from 2020 to 2021.
Former Global Head-Healthcare Investment Banking at Lehman Brothers Holdings, Inc. from 2007 to 2008.
Former Global Head-Healthcare at Citigroup, Inc. from 2008 to 2020.
Former Global Head-Healthcare at Community IT Innovators, Inc. Education includes graduate and MBA degrees from the University of Pittsburgh and an undergraduate degree from Lehigh University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ROYALTY PHARMA PLC 5,05% | 06/04/2026 | 1.238.789 ( 5,05% ) | 72 M $ | 31/07/2026 |
| 06/04/2026 | 866.410 ( 0,36% ) | 51 M $ | 31/07/2026 | |
| 19/08/2026 | 393.601 ( 0,09% ) | 23 M $ | 31/07/2026 | |
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 0,14% | 14/02/2025 | 300.000 ( 0,14% ) | 18 M $ | 31/07/2026 |
-.--% | 16/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| 24/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ROYALTY PHARMA PLC | Corporate Officer/Principal | 01/03/2020 |
| VERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/03/2026 |
RP Management LLC
 RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Direttore/Membro del Consiglio | 01/03/2020 |
FasterCures | Direttore/Membro del Consiglio | - |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ACCELERON PHARMA INC. | Direttore/Membro del Consiglio | 19/11/2021 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/03/2020 |
Lehman Brothers Holdings, Inc.
 Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Corporate Officer/Principal | 01/09/2008 |
Community IT Innovators, Inc.
 Community IT Innovators, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Finance |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FasterCures | |
RP Management LLC
RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Finance |
Community IT Innovators, Inc.
Community IT Innovators, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
